BioLife Solutions (NASDAQ BLFS) traded down $0.10 on Thursday, hitting $5.71. 31,800 shares of the stock traded hands, compared to its average volume of 60,700. BioLife Solutions has a 12-month low of $1.69 and a 12-month high of $7.53. The firm has a market capitalization of $80.06, a P/E ratio of -13.60 and a beta of 0.27.
BioLife Solutions (NASDAQ:BLFS) last posted its quarterly earnings data on Thursday, November 9th. The medical equipment provider reported ($0.03) earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.06) by $0.03. BioLife Solutions had a negative net margin of 10.76% and a negative return on equity of 24.29%. The firm had revenue of $2.96 million for the quarter, compared to the consensus estimate of $2.60 million. sell-side analysts forecast that BioLife Solutions will post -0.21 earnings per share for the current fiscal year.
BioLife Solutions Company Profile
BioLife Solutions, Inc (BioLife) is engaged in the developing, manufacturing and marketing a portfolio of biopreservation tools and services for cells, tissues and organs, including clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management application for shippers.
Receive News & Ratings for BioLife Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLife Solutions and related companies with MarketBeat.com's FREE daily email newsletter.